Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-05-15 00:00:00 ET · period of report 2024-05-13 · accession 0001883850-24-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-15 | 2024-05-13 | REGN | SCHLEIFER LEONARD S | Pres, CEO, Bd. Co-COB, Dir | M - OptEx | $399.66 | +203.2K | 577.6K | +54% | +$81.21M |
| DM | 2024-05-15 | 2024-05-14+ | REGN | SCHLEIFER LEONARD S | Pres, CEO, Bd. Co-COB, Dir | S - Sale+OE | $979.58 | -35.9K | 397.6K | -8% | -$35.21M |
| D | 2024-05-15 | 2024-05-13 | REGN | SCHLEIFER LEONARD S | Pres, CEO, Bd. Co-COB, Dir | F - Tax | $976.79 | -144.4K | 433.2K | -25% | -$141.08M |
| D | 2024-05-15 | 2024-05-13 | REGN | SCHLEIFER LEONARD S | Pres, CEO, Bd. Co-COB, Dir | M - OptEx | $0.00 | -203.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-13 | M | A | 203,204 | $399.66 | 577,633 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-15 | S | D | 299 | $988.76 | 397,259 | D | — | — | (F13) Represents volume-weighted average price of sales of 299 shares of Company stock on May 15, 2024 at prices ranging from $988.00 to $988.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 3 | Common | Common Stock | 2024-05-13 | F | D | 144,433 | $976.79 | 433,200 | D | — | — | |
| 4 | Common | Common Stock | 2024-05-14 | S | D | 22,698 | $979.16 | 410,502 | D | — | — | (F2) Represents volume-weighted average price of sales of 22,698 shares of Company stock on May 14, 2024 at prices ranging from $979.00 to $979.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2024 at each separate price. |
| 5 | Common | Common Stock | 2024-05-14 | S | D | 2,302 | $980.10 | 408,200 | D | — | — | (F3) Represents volume-weighted average price of sales of 2,302 shares of Company stock on May 14, 2024 at prices ranging from $980.00 to $980.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2024 at each separate price. |
| 6 | Common | Common Stock | 2024-05-15 | S | D | 7,864 | $979.05 | 400,336 | D | — | — | (F4) Represents volume-weighted average price of sales of 7,864 shares of Company stock on May 15, 2024 at prices ranging from $979.00 to $979.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 7 | Common | Common Stock | 2024-05-15 | S | D | 295 | $980.64 | 400,041 | D | — | — | (F5) Represents volume-weighted average price of sales of 295 shares of Company stock on May 15, 2024 at prices ranging from $980.17 to $980.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 8 | Common | Common Stock | 2024-05-15 | S | D | 1,081 | $981.50 | 398,960 | D | — | — | (F6) Represents volume-weighted average price of sales of 1,081 shares of Company stock on May 15, 2024 at prices ranging from $981.09 to $981.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 9 | Common | Common Stock | 2024-05-15 | S | D | 235 | $982.66 | 398,725 | D | — | — | (F7) Represents volume-weighted average price of sales of 235 shares of Company stock on May 15, 2024 at prices ranging from $982.31 to $982.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 10 | Common | Common Stock | 2024-05-15 | S | D | 250 | $983.91 | 398,475 | D | — | — | (F8) Represents volume-weighted average price of sales of 250 shares of Company stock on May 15, 2024 at prices ranging from $983.82 to $983.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 11 | Common | Common Stock | 2024-05-15 | S | D | 305 | $984.00 | 398,170 | D | — | — | (F9) Represents volume-weighted average price of sales of 305 shares of Company stock on May 15, 2024 at prices ranging from $984.00 to $984.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 12 | Common | Common Stock | 2024-05-15 | S | D | 281 | $985.72 | 397,889 | D | — | — | (F10) Represents volume-weighted average price of sales of 281 shares of Company stock on May 15, 2024 at prices ranging from $985.13 to $985.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 13 | Common | Common Stock | 2024-05-15 | S | D | 103 | $986.57 | 397,786 | D | — | — | (F11) Represents volume-weighted average price of sales of 103 shares of Company stock on May 15, 2024 at prices ranging from $986.37 to $986.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 14 | Common | Common Stock | 2024-05-15 | S | D | 228 | $987.46 | 397,558 | D | — | — | (F12) Represents volume-weighted average price of sales of 228 shares of Company stock on May 15, 2024 at prices ranging from $987.31 to $987.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price. |
| 15 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-05-13 | M | D | 203,204 | $0.00 | 0 | D | $399.66 · — to 2024-12-16 | 203,204 Common Stock | (F14) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |